Sillajen – South Korea
SillaJen, Inc. is a privately-held biotechnology company focusing on engineering and developing best-in-class oncolytic immunotherapeutics. SillaJen has Korean offices in Busan (R&D), at Pusan National University (PNU), and in Seoul (finance, management & legal). SillaJen also has Clinical R&D, regulatory affairs and CMC capabilities in San Francisco, California, one of the world’s leading biotechnology centers and the “birthplace” of the biotech industry. SillaJen products are engineered from vaccinia which has unique attributes as an oncolytic immunotherapy.
- 3rd Floor Hyowon IC Building Pusan Nat. Univ. Busandaehak-ro 63beon-gil, Geurmjeon-gu, Busan, Korea
- +82 (51) 510-7550
- 18th Floor, Korea Teachers Pension Bldg, 27-2 Yeoeuido-dong, Yeongdeungpo-gu, Seoul, Korea
- +82 (2) 783-7551
San Francisco Office